4//SEC Filing
Lanfear Dennis M 4
Accession 0001567619-22-000821
CIK 0001512762other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:50 PM ET
Size
9.5 KB
Accession
0001567619-22-000821
Insider Transaction Report
Form 4
Lanfear Dennis M
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-04+402,500→ 402,500 totalExercise: $15.94Exp: 2032-01-04→ Common Stock (402,500 underlying) - Award
Common Stock
2022-01-04+86,250→ 579,508 total
Holdings
- 436,684(indirect: By Trust)
Common Stock
- 86,965(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 86,250 RSUs.
- [F3]These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
- [F4]These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
- [F5]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001420822
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:50 PM ET
- Size
- 9.5 KB